NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information. Our technical rating for NeoGenomics, Inc. is neutral today. Note that market conditions change all the time — according to our 1 week rating the buy trend is. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Electric Co General is the largest individual Neogenomics shareholder, owning M shares representing % of the company. Electric Co General's. Earnings announcements can affect a stock's price. This table shows the stock's price the day before and the day after recent earnings reports, including the.
Company”), and NeoGenomics, Inc. a Nevada Corporation, (the “Purchaser share (the “Common Stock”), of the Company. The Firm Shares consist of. NEOGENOMIC, INC, a Nevada corporation with Amended and Restated Equity Incentive Plan. Exhibit PERFORMANCE STOCK UNIT AWARD AGREEMENT NEOGENOMICS. Neogenomics Inc NEO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date12/22/23 · 52 Week Low · NeoGenomics has a total shareholder equity of $M and total debt of $M, which brings its debt-to-equity ratio to 55%. Its total assets and total. - Number of outstanding shares of NEOGENOMICS: - Average share price of NEO during week $ - Multiplying the two values above. Company Name, NeoGenomics, Inc. ; Stock Symbol, NEO ; Class Period, February 27, to April 26, ; Lead Plaintiff Motion Deadline, February 06, NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates. NeoGenomics (NEO) delivered earnings and revenue surprises of % and %, respectively, for the. Salary, bonuses, stock options, stock awards and other compensation information for top executives at NEOGENOMICS INC. Explore NEO - Neogenomics Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to Historical stock prices. Current Share Price, US$ 52 Week High, US$ 52 Week Low, US$ Beta, 11 Month Change, %. NEONasdaq Stock Market • delayed by 15 minutes • USD. NEOGENOMICS, INC. (NEO). at close. + (+%). after hours • as of Aug 23, PM EDT.
Our technical rating for NeoGenomics, Inc. is neutral today. Note that market conditions change all the time — according to our 1 week rating the buy trend is. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical. Why Shares of NeoGenomics Jumped % This Week. The cancer screening company showed its turnaround may be working. Jim Halley | Nov 11, Company Info · Overview · Executive Team · Tear Sheet · FAQ · Financial Info · Financial Results · Income Statement · Balance Sheet · Cash Flow · Stock Info. Volume, K. Market Value, $B. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. The average Director base salary at NeoGenomics is $K per year. The average additional pay is $44K per year, which could include cash bonus, stock. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. The latest Neogenomics stock prices, stock quotes, news, and NEO history to help you invest and trade smarter. NEONasdaq Stock Market • delayed by 15 minutes • USD. NEOGENOMICS, INC. (NEO). at close. + (+%). after hours • as of Aug 30, PM EDT.
NeoGenomic Redeems Series A Redeemable Preferred Stock for $M. Apr 26, 10x Genomics Closes $50M Financing Round, $75M Credit Facility. Mar 26, Discover real-time NeoGenomics, Inc. Common Stock (NEO) stock prices, quotes, historical data, news, and Insights for informed trading and investment. NeoGenomics Laboratories is comprised of a national team of experts in developing and delivering laboratory diagnostic and clinical trial services with a focus. share for NeoGenomic's common stock on January 6, In addition, the NeoGenomics License provides for milestone payments in cash or stock, based on. We have company k match along with an Employee Stock Purchase Program. We have tuition reimbursement, leadership development, Accessioning Technician I.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida;.
💹 Any NIO Stock Gains Left?